Loading
Latest filing published 15 Jul 2025 for Milestone Pharmaceuticals Inc..
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Debra K. Liebert in Milestone Pharmaceuticals Inc. The record holds 3 filings, for trades running from 14 September 2022 to 11 July 2025.
Every open-market trade on record is a purchase: 1 purchase worth €54k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.
The newest entry dates from 15 July 2025: a share grant, in Milestone Pharmaceuticals Inc. The last purchase on record was published on 21 October 2022, which is 1,464 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations